ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001